599 related articles for article (PubMed ID: 14748409)
1. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
2. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
Kuca K; Cabal J; Jun D; Musilek K
Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
[TBL] [Abstract][Full Text] [Related]
3. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Kuca K; Cabal J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
[TBL] [Abstract][Full Text] [Related]
4. New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications.
Kuca K; Bartosová L; Jun D; Patocka J; Cabal J; Kassa J; Kunesová G
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):75-82. PubMed ID: 16170392
[TBL] [Abstract][Full Text] [Related]
5. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Kuca K; Jun D; Bajgar J
Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
[TBL] [Abstract][Full Text] [Related]
6. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
Worek F; Widmann R; Knopff O; Szinicz L
Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
Kuca K; Jun D
J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
Worek F; Aurbek N; Thiermann H
J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
[TBL] [Abstract][Full Text] [Related]
12. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
Jun D; Kuca K; Picha J; Koleckar V; Marek J
Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the ability of a new bispyridinium oxime--1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Kassa J
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):529-35. PubMed ID: 15008517
[TBL] [Abstract][Full Text] [Related]
15. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
[TBL] [Abstract][Full Text] [Related]
16. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
Kassa J; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
[TBL] [Abstract][Full Text] [Related]
17. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
18. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
Antonijevic B; Stojiljkovic MP
Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
20. In vitro reactivation of acetylcholinesterase inhibited by cyclosarin using bisquaternary pyridinium aldoximes K005, K033, K027 AND K048.
Kuca K; Sevelová-Bartosová L; Krejcová-Kunesová G
Acta Medica (Hradec Kralove); 2004; 47(2):107-9. PubMed ID: 15446359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
